These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16775455)

  • 1. Genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Frick KK; Nehrke K
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):403-18. PubMed ID: 16775455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation between bone and stone formation.
    Krieger NS; Bushinsky DA
    Calcif Tissue Int; 2013 Oct; 93(4):374-81. PubMed ID: 23247537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
    Bushinsky DA; Neumann KJ; Asplin J; Krieger NS
    Kidney Int; 1999 Jan; 55(1):234-43. PubMed ID: 9893132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Laplante K; Asplin JR
    Kidney Int; 2006 May; 69(9):1586-92. PubMed ID: 16557225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat.
    Frick KK; Krieger NS; Bushinsky DA
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):336-44. PubMed ID: 26050120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic hypercalciuric stone-forming rats.
    Bushinsky DA
    Curr Opin Nephrol Hypertens; 1999 Jul; 8(4):479-88. PubMed ID: 10491744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25(OH)ā‚‚Dā‚ƒ-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet.
    Frick KK; Asplin JR; Krieger NS; Culbertson CD; Asplin DM; Bushinsky DA
    Am J Physiol Renal Physiol; 2013 Oct; 305(8):F1132-8. PubMed ID: 23926184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.
    Frick KK; Asplin JR; Culbertson CD; Granja I; Krieger NS; Bushinsky DA
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1081-7. PubMed ID: 24573387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming rats.
    Krieger NS; Asplin J; Granja I; Chen L; Spataru D; Wu TT; Grynpas M; Bushinsky DA
    Kidney Int; 2021 May; 99(5):1118-1126. PubMed ID: 33417997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones.
    Messa P; Marangella M; Paganin L; Codardini M; Cruciatti A; Turrin D; Filiberto Z; Mioni G
    Clin Sci (Lond); 1997 Sep; 93(3):257-63. PubMed ID: 9337641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium Decreases Urine Supersaturation but Not Calcium Oxalate Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.
    Li Q; Krieger NS; Yang L; Asplin J; Bushinsky DA
    Nephron; 2024; 148(7):480-486. PubMed ID: 38262368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Michalenka AC; Strutz KL; Donahue S; Asplin JR
    Kidney Int; 2008 Feb; 73(4):423-9. PubMed ID: 18046318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats.
    Karnauskas AJ; van Leeuwen JP; van den Bemd GJ; Kathpalia PP; DeLuca HF; Bushinsky DA; Favus MJ
    J Bone Miner Res; 2005 Mar; 20(3):447-54. PubMed ID: 15746989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats.
    Evan AP; Bledsoe SB; Smith SB; Bushinsky DA
    Kidney Int; 2004 Jan; 65(1):154-61. PubMed ID: 14675046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium and vitamin D have a synergistic role in a rat model of kidney stone disease.
    Letavernier E; Verrier C; Goussard F; Perez J; Huguet L; Haymann JP; Baud L; Bazin D; Daudon M
    Kidney Int; 2016 Oct; 90(4):809-17. PubMed ID: 27475231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.